Long-term effects of a multifaceted intervention to encourage the choice of the oral route for proton pump inhibitors: an interrupted time-series analysis

Qual Saf Health Care. 2009 Jun;18(3):232-5. doi: 10.1136/qshc.2007.023887.

Abstract

Problem: Drugs are often given intravenously even when the patient is able to swallow and when an oral form would be more cost-effective.

Design: Evaluation of the impact of a multifaceted intervention on the early switch from intravenous to oral administration of proton pump inhibitors (PPI) in a hospital setting. The interrupted time series of intravenous PPI consumption was analysed.

Background and setting: At a French University Hospital, the Drug Committee, composed of multidisciplinary pharmacy and medical staff, addressed the issue of increasing consumption of intravenous PPI drugs (May 2003).

Strategy for change: Letters to department heads, academic analyses from members of the Drug Committee, paper reminders at the point of care and audit-feedbacks by pharmacists. Monitoring of consumption and repeated reminder letters were planned. EFFECT OF CHANGE: The consumption of PPI was stable before the first intervention (mean level: 954 units/month). An immediate decrease occurred after the first Drug Committee letter (30% relative reduction, 95% CI -16% to -46%; p<0.001) with a significant trend change during the first multifaceted intervention (-24 units/month, 95% CI -42 to -7; p = 0.007). After the end of the outreach visits (July 2004), the consumptions increased (+32 units/month, 95% CI: 14 to 50, p<0.001). The second intervention had no significant impact.

Lessons learnt: A complex intervention (audit, feedbacks, outreach visits) had an effect on practice. It was not sustained even after a less resource-intensive intervention. Other types of interventions are needed that could be continuously implemented to improve ordering practices long term.

Publication types

  • Evaluation Study

MeSH terms

  • Administration, Oral
  • France
  • Guideline Adherence
  • Humans
  • Infusions, Intravenous
  • Practice Patterns, Physicians' / statistics & numerical data*
  • Proton Pump Inhibitors / administration & dosage*
  • Reminder Systems

Substances

  • Proton Pump Inhibitors